F
GMAB icon

Folketrygdfondet’s Genmab GMAB Stock Holding History

Folketrygdfondet’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Buy
165,082
+4,309
+3% +$115K 0.1% 10
2026
Q1 		$4.31M Sell
160,773
-14,032
-8% -$421K 0.08% 11
2025
Q4 		$5.38M Hold
174,805
– – 0.13% 9
2025
Q3 		$5.36M Buy
174,805
+2,009
+1% +$49K 0.13% 9
2025
Q2 		$3.57M Buy
172,796
+2,411
+1% +$49.5K 0.08% 10
2025
Q1 		$3.34M Hold
170,385
– – 0.07% 10
2024
Q4 		$3.56M Hold
170,385
– – 0.08% 11
2024
Q3 		$4.15M Hold
170,385
– – 0.08% 12
2024
Q2 		$4.28M Hold
170,385
– – 0.08% 13
2024
Q1 		$5.1M Hold
170,385
– – 0.11% 11
2023
Q4 		$5.43M Hold
170,385
– – 0.11% 10
2023
Q3 		$6.01M Hold
170,385
– – 0.12% 10
2023
Q2 		$6.48M Hold
170,385
– – 0.15% 10
2023
Q1 		$6.43M Buy
170,385
+10,008
+6% +$385K 0.15% 10
2022
Q4 		$6.8M Buy
160,377
+3,311
+2% +$136K 0.14% 10
2022
Q3 		$5.05M Hold
157,066
– – 0.11% 10
2022
Q2 		$5.1M Buy
157,066
+152,100
+3,063% +$4.93M 0.11% 10
2022
Q1 		$137K Sell
4,966
-132,685
-96% -$4.55M 0.08% 9
2021
Q4 		$5.45M Hold
137,651
– – 0.13% 10
2021
Q3 		$6.02M Sell
137,651
-3,656
-3% -$164K 0.15% 10
2021
Q2 		$5.77M Buy
141,307
+23,317
+20% +$900K 0.17% 9
2021
Q1 		$3.87M Sell
117,990
-69,578
-37% -$2.62M 0.13% 9
2020
Q4 		$7.63M Hold
187,568
– – 0.28% 8
2020
Q3 		$6.87M Hold
187,568
– – 0.29% 8
2020
Q2 		$63.6M Hold
187,568
– – 2.57% 5
2020
Q1 		$39.7M Buy
187,568
+12,000
+7% +$267K 1.92% 6
2019
Q4 		$39.2M Hold
175,568
– – 1.28% 9
2019
Q3 		$3.56M Buy
+175,568
New +$3.46M 0.12% 10

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Folketrygdfondet's GMAB Position: Q2 2026 in Review

Folketrygdfondet increased its Genmab (GMAB) stake by 2.7% in Q2 2026, buying an estimated $115K and bringing the position to 165,082 shares worth $4.53M. The position accounts for 0.1% of the portfolio, ranked #10.

Folketrygdfondet first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $63.6M in Q2 2020. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Folketrygdfondet held 165,082 shares of Genmab worth $4.53M as of Q2 2026.
  • Folketrygdfondet bought 4,309 Genmab shares in Q2 2026, an estimated $115K.
  • Genmab made up 0.1% of Folketrygdfondet's portfolio in Q2 2026, its #10 holding.
  • Folketrygdfondet first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • Folketrygdfondet's Genmab position peaked at $63.6M in Q2 2020.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Folketrygdfondet's 13F filing for Q2 2026, filed 13 Aug 2026.